Form 4 Filing for Evommune, Inc.

Arthur S. Kirsch, a director at Evommune, Inc., acquired 10,000 shares of common stock on July 7, 2026. The purchase was made through a family trust, with Kirsch acting as trustee. The shares were bought at a weighted average price of $13.30, with individual transactions ranging from $13.25 to $13.35. This transaction is reported on Form 4, indicating a change in beneficial ownership. Kirsch disclaims beneficial ownership except to the extent of his proportionate pecuniary interest.